Free Trial
→ The chokepoint supplier behind SpaceX's $1.75 trillion empire (From Behind the Markets) (Ad)tc pixel Free CCJ Stock Alerts

Cameco (CCJ) Financials

Cameco logo
$105.04 -2.47 (-2.30%)
Closing price 03:59 PM Eastern
Extended Trading
$105.06 +0.02 (+0.02%)
As of 05:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Cameco

Annual Income Statements for Cameco

This table shows Cameco's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -43 -56 154 21 -90 -134 62 143 223 215
Consolidated Net Income / (Loss)		 -45 -163 122 57 -42 -80 62 273 119 430
Net Income / (Loss) Continuing Operations		 -45 -56 154 21 -90 -134 62 143 223 215
Total Pre-Tax Income 		-115 -58 61 21 -79 -135 62 238 282 567
Total Operating Income		 -88 -28 -16 21 -44 -92 -9.00 314 383 451
Total Gross Profit		 345 347 217 186 83 1.51 172 425 543 708
Total Revenue		 1,809 0.00 0.00 26 1,420 1,160 0.00 2,045 2,192 2,539
Operating Revenue		 1,809 - - 26 1,420 1,160 - 2,045 2,192 2,539
Total Cost of Revenue		 1,188 0.00 0.00 0.00 1,328 1,153 0.00 1,535 1,634 1,832
Operating Cost of Revenue		 1,188 - - - 1,328 1,153 - 1,535 1,634 1,832
Total Operating Expenses		 710 28 16 4.67 136 99 9.00 196 175 468
Selling, General & Admin Expense		 154 - - - - - - - - 227
Research & Development Expense		 3.69 4.50 1.29 4.67 3.11 5.61 9.00 16 25 28
Exploration Expense		 32 24 15 - - - - - - 20
Depreciation Expense		 277 - - - - - - - - 214
Other Operating Expenses / (Income)		 -25 - - - 133 93 - 180 150 -21
Impairment Charge		 269 - - - - - - - - 0.00
Total Other Income / (Expense), net		 -27 -30 78 0.00 -35 -43 71 -75 -102 113
Interest Expense		 83 5.52 1.69 - - - 0.38 - - 84
Interest & Investment Income		 3.26 - - - - - - - - 17
Other Income / (Expense), net		 54 -24 79 - -35 -43 72 -75 -102 180
Income Tax Expense		 -70 -2.00 -93 - 11 -0.94 - 96 59 137
Weighted Average Basic Shares Outstanding		 - 395.79M 395.79M 395.80M 396.26M 398.06M 432.52M 434.18M 435.31M 435.46M
Weighted Average Diluted Shares Outstanding		 - 395.79M 395.79M 395.80M 396.26M 398.06M 432.52M 434.18M 435.31M 435.46M
Weighted Average Basic & Diluted Shares Outstanding		 - 395.79M 395.79M 395.80M 396.26M 398.06M 432.52M 434.18M 435.31M 435.46M

Quarterly Income Statements for Cameco

No quarterly income statements for Cameco are available.

Annual Cash Flow Statements for Cameco

This table details how cash moves in and out of Cameco's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -100 219 82 276 -111 259 -115 -222 -749 388
Net Cash From Operating Activities		 232 474 489 406 45 359 -19 -129 105 1,027
Net Cash From Continuing Operating Activities		 234 449 519 389 39 359 -19 -129 105 1,046
Net Income / (Loss) Continuing Operations		 -45 -163 122 57 -42 -80 66 273 119 430
Consolidated Net Income / (Loss)		 -45 -163 122 57 -42 -80 66 273 119 430
Depreciation Expense		 277 263 240 213 164 149 - - - 214
Non-Cash Adjustments To Reconcile Net Income		 148 403 243 73 -98 181 2.83 4.45 5.43 143
Changes in Operating Assets and Liabilities, net		 -146 -53 -94 57 15 109 -88 -407 -19 260
Net Cash From Investing Activities		 -162 -74 -302 337 -79 -63 -106 -116 -147 -316
Net Cash From Continuing Investing Activities		 -160 -89 -326 244 -80 -120 -106 -116 -147 -315
Purchase of Property, Plant & Equipment		 -161 -91 -41 -58 -61 -77 -106 -116 -147 -243
Acquisitions		 - - - - - 0.00 - - - 0.00
Sale of Property, Plant & Equipment		 1.61 1.55 0.92 0.52 0.40 4.19 - - - 0.18
Other Investing Activities, net		 - 0.00 -287 301 -20 -47 - - - -73
Net Cash From Financing Activities		 -170 -181 -106 -468 -77 -37 0.00 0.00 -723 -323
Net Cash From Continuing Financing Activities		 -170 -181 -106 -468 -77 -37 0.00 0.00 -723 -323
Repayment of Debt		 -52 -55 -53 -443 -368 -33 0.00 0.00 -723 -248
Payment of Dividends		 -118 -126 -52 -24 -25 -25 - - - -76
Issuance of Common Equity		 0.00 0.00 0.00 0.06 4.21 21 - - - 1.58

Quarterly Cash Flow Statements for Cameco

No quarterly cash flow statements for Cameco are available.

Annual Balance Sheets for Cameco

This table presents Cameco's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 6,139 6,182 5,876 5,724 5,943 5,884 6,380 7,525 6,880 7,513
Total Current Assets		 1,519 1,697 1,526 1,393 1,525 1,676 2,455 1,395 1,336 1,925
Cash & Equivalents		 238 470 521 819 720 976 845 429 417 813
Accounts Receivable		 180 315 295 253 161 216 136 320 241 263
Inventories, net		 958 755 343 247 533 321 491 524 574 616
Prepaid Expenses		 126 119 65 66 70 75 117 113 101 123
Current Deferred & Refundable Income Taxes		 8.60 9.07 5.13 2.83 6.42 3.89 0.78 0.74 1.79 8.73
Other Current Assets		 - 0.00 - 0.00 - - - - 0.00 73
Plant, Property, & Equipment, net		 3,465 3,331 2,845 2,867 2,957 2,799 2,567 2,552 2,282 2,425
Total Noncurrent Assets		 773 740 954 978 950 956 918 3,113 2,848 2,691
Long-Term Investments		 0.00 0.00 169 195 172 183 156 2,404 2,235 2,178
Goodwill		 - 56 - - - - - - 28 26
Noncurrent Deferred & Refundable Income Taxes		 622 684 737 737 734 734 727 676 586 486
Total Liabilities & Shareholders' Equity		 6,139 6,182 5,876 5,724 5,943 5,884 6,380 7,525 6,880 7,513
Total Liabilities		 2,226 2,220 2,217 1,874 2,056 2,091 2,067 2,908 2,208 2,202
Total Current Liabilities		 349 327 642 214 238 324 414 901 823 780
Short-Term Debt		 - 0.00 366 0.00 0.00 0.00 0.00 379 352 98
Accounts Payable		 233 205 165 140 183 266 277 437 430 635
Current Deferred & Payable Income Tax Liabilities		 27 16 14 4.85 1.16 3.23 4.80 18 15 12
Other Current Liabilities		 89 74 97 69 54 54 133 66 26 35
Total Noncurrent Liabilities		 1,876 1,993 1,575 1,661 1,817 1,767 1,652 2,008 1,637 1,698
Long-Term Debt		 1,111 1,188 730 768 780 780 737 973 691 727
Other Noncurrent Operating Liabilities		 753 695 845 893 1,037 988 916 1,035 693 695
Total Equity & Noncontrolling Interests		 3,913 3,862 3,659 3,849 3,887 3,793 4,313 4,616 4,420 5,035
Total Preferred & Common Equity		 3,913 3,862 3,659 3,849 3,887 3,793 4,313 4,616 4,420 5,035
Preferred Stock		 - 179 172 181 186 180 166 163 146 154
Total Common Equity		 3,913 3,683 3,487 3,668 3,701 3,613 4,147 4,453 4,273 4,880
Common Stock		 1,386 1,480 1,365 1,436 1,466 1,490 2,129 2,207 2,038 2,143
Retained Earnings		 2,247 2,106 2,045 2,178 2,145 2,066 1,993 2,257 2,152 2,632
Accumulated Other Comprehensive Income / (Loss)		 119 96 76 55 91 57 26 -12 83 106
Noncontrolling Interest		 0.12 0.29 0.23 0.18 0.16 0.10 0.01 0.00 0.02 0.01

Quarterly Balance Sheets for Cameco

No quarterly balance sheets for Cameco are available.

Annual Metrics And Ratios for Cameco

This table displays calculated financial ratios and metrics derived from Cameco's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - - - - - - - - - 435,457,978.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 435,457,978.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - 0.49
Growth Metrics		 - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 -62 -20 -40 21 -31 -64 -9.00 188 303 342
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 3.15% 5.71% 5.84%
Earnings before Interest and Taxes (EBIT)		 -35 -52 63 21 -79 -135 63 238 282 631
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 242 210 311 224 85 14 63 238 282 844
Valuation Ratios		 - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 108 1,011 125 -147 289 124 269 722 348
Efficiency Ratios		 - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 4,397 4,269 3,217 3,113 3,230 2,877 2,744 2,662 2,243 2,643
Increase / (Decrease) in Invested Capital		 0.00 -128 -1,052 -104 117 -353 -133 -81 -419 -6.40
Book Value per Share		 $0.00 $9.31 $8.81 $9.27 $9.35 $9.12 $10.42 $10.30 $9.84 $11.21
Tangible Book Value per Share		 $0.00 $9.16 $8.69 $9.15 $9.24 $9.02 $10.33 $10.22 $9.78 $11.15
Total Capital		 5,024 5,050 4,755 4,618 4,667 4,572 5,050 5,968 5,309 5,859
Total Debt		 1,111 1,188 1,096 768 780 780 737 1,351 890 825
Total Long-Term Debt		 1,111 1,188 730 768 780 780 737 973 691 727
Net Debt		 873 717 119 -245 -131 -446 -1,105 -1,481 -1,762 -2,167
Capital Expenditures (CapEx)		 160 89 40 57 60 73 106 116 147 243
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 932 900 443 360 547 310 354 444 294 429
Debt-free Net Working Capital (DFNWC)		 1,170 1,370 1,250 1,179 1,287 1,352 2,040 873 711 1,242
Net Working Capital (NWC)		 1,170 1,370 884 1,179 1,287 1,352 2,040 494 512 1,144
Net Nonoperating Expense (NNE)		 -17 143 -162 -36 11 16 -71 -86 184 -88
Net Nonoperating Obligations (NNO)		 484 407 -442 -736 -657 -916 -1,569 -1,954 -2,177 -2,392
Total Depreciation and Amortization (D&A)		 277 263 248 202 164 149 0.00 0.00 0.00 214
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($0.52) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 0.00 395.79M 395.79M 395.80M 396.26M 398.06M 432.52M 434.18M 435.31M 435.46M
Adjusted Diluted Earnings per Share		 $0.00 ($0.52) $0.42 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 395.79M 395.79M 395.80M 396.26M 398.06M 432.52M 434.18M 435.31M 435.46M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 395.79M 395.79M 395.80M 396.26M 398.06M 432.52M 434.18M 435.31M 435.46M
Normalized Net Operating Profit after Tax (NOPAT)		 127 -20 -11 15 -31 -64 -6.30 188 303 342
Debt Service Ratios		 - - - - - - - - - -
Payout Ratios		 - - - - - - - - - -

Quarterly Metrics And Ratios for Cameco

No quarterly metrics and ratios for Cameco are available.


Financials Breakdown Chart

Cameco Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Cameco's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Cameco's net income appears to be on an upward trend, with a most recent value of $429.95 million in 2025, falling from -$44.56 million in 2016. The previous period was $119.33 million in 2024. Check out Cameco's forecast to explore projected trends and price targets.

Cameco's total operating income in 2025 was $450.80 million, based on the following breakdown:
  • Total Gross Profit: $707.61 million
  • Total Operating Expenses: $468.28 million

Over the last 9 years, Cameco's total revenue changed from $1.81 billion in 2016 to $2.54 billion in 2025, a change of 40.3%.

Cameco's total liabilities were at $2.20 billion at the end of 2025, a 0.2% decrease from 2024, and a 1.0% decrease since 2016.

In the past 9 years, Cameco's cash and equivalents has ranged from $238.34 million in 2016 to $976.32 million in 2021, and is currently $813.05 million as of their latest financial filing in 2025.

Over the last 9 years, Cameco's book value per share changed from 0.00 in 2016 to 11.21 in 2025, a change of 1,121.1%.


Related Companies

Financial statements for NYSE:CCJ last updated on 3/23/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Peptide Company Lands Exclusive MMA Wellness Partnership
The Precision Peptide Company (OTCQB: PNGAF) just signed an exclusive partnership with a NYSE-listed MMA media...
The Tomorrow Investor | Sponsoredtc pixel
Musk’s warning just revealed a $1T opportunity
Elon Musk recently warned that AI could force governments to introduce universal income. Mode Mobile isn't wai...
Mode Mobile | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
The smartest SpaceX play before Memorial Day
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
Your $29.97 book is free today
Bill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...
Profits Run | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel